Industry
Biotechnology
Enveric Biosciences, Inc., a pharmaceutical company, engages in developing various cannabinoid medicines for cancer care. Its products pipeline includes EV104 for the treatment of osteoarthritis; EVM-101 and EVM-201 for the treatment of cancer related distress; EVM-301 for the treatment of mental health indication; EV102, a cannabinoid cream for topical skin application; and EV101, a cannabinoid and chemotherapy combination therapy. Enveric Biosciences, Inc. is headquartered in Naples, Florida.
Loading...
Open
N/A
Mkt cap
N/A
Volume
N/A
High
N/A
P/E Ratio
N/A
52-wk high
N/A
Low
N/A
Div yield
N/A
52-wk low
N/A
Portfolio Pulse from Benzinga Newsdesk
August 20, 2024 | 7:54 pm
Portfolio Pulse from Benzinga Newsdesk
August 13, 2024 | 12:08 pm
Portfolio Pulse from Benzinga Newsdesk
August 12, 2024 | 9:39 pm
Portfolio Pulse from Avi Kapoor
July 30, 2024 | 5:53 pm
Portfolio Pulse from Avi Kapoor
July 30, 2024 | 9:50 am
Portfolio Pulse from Nina Zdinjak
July 25, 2024 | 12:00 pm
Portfolio Pulse from Benzinga Newsdesk
July 16, 2024 | 6:51 pm
Portfolio Pulse from Benzinga Newsdesk
July 15, 2024 | 12:12 pm
Portfolio Pulse from Benzinga Newsdesk
June 25, 2024 | 12:03 pm
Portfolio Pulse from Benzinga Newsdesk
June 12, 2024 | 6:07 pm
All corporate logos and prices are for illustrative purposes only and are not a recommendation, an offer to sell, or a solicitation of an offer to buy any security.